Contribution of the Lung to the Genesis of Cheyne-Stokes Respiration in Heart Failure: Plant Gain Beyond Chemoreflex Gain and Circulation Time.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
02 07 2019
Historique:
entrez: 26 6 2019
pubmed: 27 6 2019
medline: 21 10 2020
Statut: ppublish

Résumé

Background The contribution of the lung or the plant gain ( PG ; ie, change in blood gases per unit change in ventilation) to Cheyne-Stokes respiration ( CSR ) in heart failure has only been hypothesized by mathematical models, but never been directly evaluated. Methods and Results Twenty patients with systolic heart failure (age, 72.4±6.4 years; left ventricular ejection fraction, 31.5±5.8%), 10 with relevant CSR (24-hour apnea-hypopnea index [ AHI ] ≥10 events/h) and 10 without ( AHI <10 events/h) at 24-hour cardiorespiratory monitoring underwent evaluation of chemoreflex gain (CG) to hypoxia ([Formula: see text]) and hypercapnia ([Formula: see text]) by rebreathing technique, lung-to-finger circulation time, and PG assessment through a visual system. PG test was feasible and reproducible (intraclass correlation coefficient, 0.98; 95% CI , 0.91-0.99); the best-fitting curve to express the PG was a hyperbola ( R

Identifiants

pubmed: 31237174
doi: 10.1161/JAHA.119.012419
pmc: PMC6662365
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e012419

Références

Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76
pubmed: 11316667
Am J Cardiol. 2011 Jun 1;107(11):1675-80
pubmed: 21420051
Am J Respir Crit Care Med. 2000 Dec;162(6):2194-200
pubmed: 11112137
J Am Heart Assoc. 2019 Jul 2;8(13):e012419
pubmed: 31237174
Clin Chem Lab Med. 2004;42(6):627-36
pubmed: 15259379
J Am Coll Cardiol. 2009 May 26;53(21):1975-80
pubmed: 19460611
Am J Respir Crit Care Med. 2006 Jan 15;173(2):234-7
pubmed: 16239622
J Am Coll Cardiol. 2017 Sep 12;70(11):1351-1364
pubmed: 28882233
Adv Exp Med Biol. 2015;860:167-85
pubmed: 26303479
J Appl Physiol (1985). 2018 Nov 1;125(5):1490-1497
pubmed: 30161007
J Am Coll Cardiol. 2010 Nov 23;56(22):1832-7
pubmed: 21087712
Circulation. 2008 Sep 2;118(10):1080-111
pubmed: 18725495
J Appl Physiol. 1966 Nov;21(6):1839-46
pubmed: 5929311
Eur Heart J. 2016 Jun 1;37(21):1695-703
pubmed: 26612581
Eur Heart J. 2011 Jan;32(1):61-74
pubmed: 20846992
N Engl J Med. 2005 Nov 10;353(19):2025-33
pubmed: 16282177
J Am Soc Echocardiogr. 2016 Apr;29(4):277-314
pubmed: 27037982
Am J Respir Crit Care Med. 2002 May 1;165(9):1245-50
pubmed: 11991873
J Appl Physiol (1985). 1988 Sep;65(3):1400-9
pubmed: 3141356
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Chest. 2008 Jul;134(1):67-72
pubmed: 18198261
Circulation. 2001 Jul 31;104(5):544-9
pubmed: 11479251
N Engl J Med. 2015 Sep 17;373(12):1095-105
pubmed: 26323938
Am J Respir Crit Care Med. 2005 Dec 1;172(11):1363-70
pubmed: 16100008
Int J Cardiol. 2015 Feb 15;181:14-6
pubmed: 25479531
Clin Med Insights Cardiol. 2015 Oct 29;9(Suppl 1):133-42
pubmed: 26561001
N Engl J Med. 1999 Sep 23;341(13):949-54
pubmed: 10498490
J Am Coll Cardiol. 2009 Jul 28;54(5):375-85
pubmed: 19628111
J Am Coll Cardiol. 1992 Jul;20(1):248-54
pubmed: 1351488
Am Rev Respir Dis. 1974 Mar;109(3):345-50
pubmed: 4814696
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):376-81
pubmed: 8756809
J Appl Physiol (1985). 2009 Mar;106(3):850-6
pubmed: 19118158
Circulation. 1999 Dec 14;100(24):2418-24
pubmed: 10595954
J Card Fail. 2016 Nov;22(11):921-924
pubmed: 26571148
Respir Physiol. 2000 Sep;122(2-3):167-82
pubmed: 10967342
Chest. 2003 May;123(5):1551-60
pubmed: 12740273
Adv Exp Med Biol. 2018;1071:129-136
pubmed: 30357743
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Clin Sci (Lond). 2008 Apr;114(7):489-97
pubmed: 17961123
J Am Coll Cardiol. 1996 May;27(6):1486-90
pubmed: 8626963
Eur Respir J. 1998 Aug;12(2):414-9
pubmed: 9727794
Am J Physiol. 1956 Nov;187(2):395-8
pubmed: 13372802
Australas Ann Med. 1967 Feb;16(1):20-32
pubmed: 6032026
Circulation. 2000 Oct 31;102(18):2214-21
pubmed: 11056095

Auteurs

Alberto Giannoni (A)

1 Fondazione Toscana G. Monasterio Pisa Italy.
2 Institute of Life Sciences Scuola Superiore Sant'Anna Pisa Italy.

Francesco Gentile (F)

1 Fondazione Toscana G. Monasterio Pisa Italy.

Alessandro Navari (A)

1 Fondazione Toscana G. Monasterio Pisa Italy.

Chiara Borrelli (C)

1 Fondazione Toscana G. Monasterio Pisa Italy.

Gianluca Mirizzi (G)

1 Fondazione Toscana G. Monasterio Pisa Italy.

Giosuè Catapano (G)

1 Fondazione Toscana G. Monasterio Pisa Italy.

Giuseppe Vergaro (G)

1 Fondazione Toscana G. Monasterio Pisa Italy.
2 Institute of Life Sciences Scuola Superiore Sant'Anna Pisa Italy.

Francesco Grotti (F)

1 Fondazione Toscana G. Monasterio Pisa Italy.

Monica Betta (M)

3 IMT School for Advanced Studies Lucca Italy.

Massimo F Piepoli (MF)

4 Heart Failure Unit Cardiology Guglielmo da Saliceto Hospital Piacenza Italy.

Darrel P Francis (DP)

5 International Center for Circulatory Health National Heart and Lung Institute Imperial College London London United Kingdom.

Claudio Passino (C)

1 Fondazione Toscana G. Monasterio Pisa Italy.
2 Institute of Life Sciences Scuola Superiore Sant'Anna Pisa Italy.

Michele Emdin (M)

1 Fondazione Toscana G. Monasterio Pisa Italy.
2 Institute of Life Sciences Scuola Superiore Sant'Anna Pisa Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH